Femoral artery closure after cardiac catheterization

Critical Care Nurse

Volumn 29, Issue 1, 2009, Pages 39-46

  Hamel, Wallace J ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMORAL ARTERY; HEART CATHETERIZATION; HEMOSTASIS; HUMAN; INSTRUMENTATION; LIGATION; NURSING; REVIEW; SAFETY; SURGICAL INSTRUMENT; SUTURE;

CONSTRICTION; FEMORAL ARTERY; HEART CATHETERIZATION; HEMOSTATIC TECHNIQUES; HUMANS; SAFETY MANAGEMENT; SURGICAL INSTRUMENTS; SUTURES;

EID: 65349122943     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: 10.4037/ccn2009157     Document Type: Article

References (31)

1. American Heart Association. Heart Disease and Stroke Statistics: 2007 Update. Dallas, TX: American Heart Association; 2007.
2. Reddy BK, Brewster PS, Walsh T, Burket MW, Thomas WJ, Cooper CJ. Randomized comparison of rapid ambulation using radial, 4 French femoral access, or femoral access with Angioseal closure. Catheter Cardiovasc Interv. 2004;62(2):143-149.
3. Turi Z. Overview of vascular closure. Endovasc Today. 2005;43:32-37.
4. Hermiller J, Simonton C, Hinohara T, et al. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol. 2005;17(10):504-510.
5. Turi ZG. The essentials of vascular access and closure [PowerPoint presentation]. April 8, 2005. http://www.tctmd.com/Show.aspx?id=58214. Accessed October 28, 2008.
6. Weisz G. Diagnosis and management of femoral site complications III: AV-fistulae, perforations, infections [PowerPoint presentation]. Oct 16,2005. www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=1354878. Accessed March 19, 2007.
7. White C. Vascular access and complications [PowerPoint presentation]. November 6, 2003. www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=862328. Accessed March 19, 2007.
8. Davis C, VanRiper S, Longstreet J, Moscucci M. Vascular complications of coronary interventions. Heart Lung. 1997;26(2):118-127.
9. Exaire JE, Tcheng JE, Kereiakes DJ, et al. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaprin, glycoprotein IIb/IIIa inhibitors and clopidogrel. Catheter Cardiovasc Intern. 2005;64(3):369-372.
10. Applegate RJ, Sacrinty M, Kutcher MA, et al. Vascular complications with newer generations of Angioseal vascular closure devices. J Interv Cardiol. 2006;19(1):67-74.
11. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. Acta Radiol. 1953;39(5):366-376.
12. Eggebrecht H, Naber C, Woertgen U, et al. Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device. Catheter Cardiovasc Intern. 2003;58(3):313-321.
13. Kim M. Vascular closure devices. Cardiol Clin. 2006;24(2):277-286.
14. Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291(3):350-357.
15. Applegate RJ, Sacrinty MT, Kutcher MA, et al. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv. 2006;67(4):556-562.
16. Arora N, Matheny M, Sepke C, Resnic F. A propensity analysis of the risk of cardiovascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007;153(4): 606-611.
17. Goyen M, Manz S, Kroger K, et al. Interventional therapy of vascular complications caused by the hemostatic puncture closure device Angio-Seal. Catheter Cardiovasc Interv. 2000;49(2):142-147.
18. Desideri A, Tonello D, Coscarelli S, et al. Early mobilization after percutaneous catheterization and vascular closure with a novel device (Star-Close). Am J Cardiol. 2005; 96(10):1408-1409.
19. Star Close Vascular Closure System [instructions for use]. Redwood City, CA: Abbott Vascular; 2007:1-17.
20. Roubin G. Rapid ambulation after CAS. Endovasc Today. 2005;4:45-46.
21. Perclose Proglide 6F Suture-Mediated Closure System [instructions for use]. Redwood City, CA: Abbott Vascular; 2005:1-10.
22. Angio-Seal [instructions for use]. Minnetonka, MN: St Jude Medical Center; 2005:1-16.
23. Cardiovascular/Cardiology News. FDA Approves StarClose Vascular Closure System, Abbott, December 26, 2005. http://www.medicalnewstoday.com/medicalnews.php?newsid=35381. Accessed October 28, 2008.
24. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol. 1999;83(12):1658-1663.
25. Rickli H, Unterweger M, Sütsch G, et al. Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Catheter Cardiovasc Interv. 2002;57(3):297-302.
26. Resnic F, Arora N, Matheny M, et al. A cost minimization analysis of the Angioseal vascular closure device following percutaneous coronary intervention. Am J Cardiol. 2007; 99(6):766-770.
27. Tagney J, Lackie D. Bed-rest post-femoral arterial sheath removal-what is safe practice? A clinical audit. Nurs Crit Care. 2005; 10(4):167-173.
28. Cardiac Cath Lab Post PCI Orders [physician's order form]. Hartford, CT: Hartford Hospital; 2005.
29. Vanderbilt University Medical Center. AngioSeal hemostatic puncture closure device, cl30-13.02 page, December 11, 2006. http://vumcpolicies.mc.vanderbilt.edu/E-Manual/Hpolicy.nsf/AllDocs/F1C0ADD32DF2B7E28625692D00603E46.
30. Discharge Instructions: Cardiac Cath/PTCA [critical path-consumer/patient teaching materials, forms] Glendale, CA: Glendale Adventist Medical Center; 1997
31. Tremko L. Understanding diagnostic cardiac catheterization. Am J Nurs. 1997;92(2):16-19.